Company
Eli Lilly & Co LLY
Tracked across 25 disclosed holders on Protégé.
16 tracked investors, latest 13F quarter ending 30 Jun 2026 · 8 members of Congress · 1 executive · latest filing 14 Aug 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Arini Capital | 1.5% | $7.2M | 2026-06-30 |
| Brevan Howard Asset Management | 1.4% | $92.5M | 2026-06-30 |
| Adage Capital Management | 1.2% | $871.0M | 2026-06-30 |
| Voleon Group | 1.2% | $63.9M | 2026-06-30 |
| Woodline Partners | 0.9% | $293.7M | 2026-06-30 |
| Samlyn Capital | 0.7% | $44.5M | 2026-06-30 |
| Ken Griffin | 0.7% | $1.1B | 2026-06-30 |
| Hudson Bay Capital Management | 0.6% | $119.9M | 2026-06-30 |
| Squarepoint Capital | 0.6% | $294.5M | 2026-06-30 |
| Holocene Advisors | 0.5% | $211.7M | 2026-06-30 |
| Cliff Asness | 0.4% | $1.2B | 2026-06-30 |
| Ray Dalio | 0.4% | $104.4M | 2026-06-30 |
| D. E. Shaw & Co. | 0.4% | $595.6M | 2026-06-30 |
| Stanley Druckenmiller | 0.3% | $14.8M | 2026-06-30 |
| Marshall Wace | 0.3% | $401.4M | 2026-06-30 |
| Centiva Capital | 0.3% | $9.5M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Gilbert Cisneros | 2 buys / 1 sell | $75K |
| Greg Landsman | 0 buys / 1 sell | -$33K |
| Josh Gottheimer | 0 buys / 2 sells | -$16K |
| Byron Donalds | 2 buys / 0 sells | $16K |
| David Taylor | 1 buy / 2 sells | -$8K |
| Marjorie Greene | 1 buy / 0 sells | $8K |
| Michael Rulli | 1 buy / 2 sells | -$8K |
| Julie Johnson | 0 buys / 1 sell | -$8K |
Company executives who disclosed trades
| Executive | Disclosed activity | Net |
|---|---|---|
| David Ricks | 1 buy / 0 sells | $1.1M |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.